688163 赛伦生物
已收盘 05-22 15:00:01
资讯
新帖
简况
每周股票复盘：赛伦生物（688163）2025年扣非净利增50.91%
证券之星 · 05-24 04:08
每周股票复盘：赛伦生物（688163）2025年扣非净利增50.91%
赛伦生物（688163）披露2025年度持续督导跟踪报告，5月19日股价下跌0.82%
证券之星 · 05-19
赛伦生物（688163）披露2025年度持续督导跟踪报告，5月19日股价下跌0.82%
每周股票复盘：赛伦生物（688163）2025年年度股东会多项议案获通过
证券之星 · 05-17
每周股票复盘：赛伦生物（688163）2025年年度股东会多项议案获通过
赛伦生物（688163）披露2025年年度股东会决议公告，5月15日股价下跌0.94%
证券之星 · 05-15
赛伦生物（688163）披露2025年年度股东会决议公告，5月15日股价下跌0.94%
赛伦生物（688163）披露首次公开发行持续督导保荐总结报告书，5月13日股价下跌5.43%
证券之星 · 05-13
赛伦生物（688163）披露首次公开发行持续督导保荐总结报告书，5月13日股价下跌5.43%
5月13日赛伦生物跌5.43%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 05-13
5月13日赛伦生物跌5.43%，中信保诚多策略混合(LOF)A基金重仓该股
赛伦生物（688163）披露抗蜂毒血清获临床试验批准通知书，5月8日股价上涨2.61%
证券之星 · 05-08
赛伦生物（688163）披露抗蜂毒血清获临床试验批准通知书，5月8日股价上涨2.61%
赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书
智通财经 · 05-07
赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书
赛伦生物（688163）披露2025年年度股东会会议资料，5月6日股价上涨0.43%
证券之星 · 05-06
赛伦生物（688163）披露2025年年度股东会会议资料，5月6日股价上涨0.43%
每周股票复盘：赛伦生物（688163）将参加2026年5月13日业绩说明会
证券之星 · 05-02
每周股票复盘：赛伦生物（688163）将参加2026年5月13日业绩说明会
4月27日赛伦生物跌5.22%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 04-27
4月27日赛伦生物跌5.22%，中信保诚多策略混合(LOF)A基金重仓该股
赛伦生物(688163)3月31日股东户数0.73万户，较上期增加8.92%
证券之星 · 04-25
赛伦生物(688163)3月31日股东户数0.73万户，较上期增加8.92%
图解赛伦生物年报：第四季度单季净利润同比增长33.41%
证券之星 · 04-25
图解赛伦生物年报：第四季度单季净利润同比增长33.41%
4月24日赛伦生物跌9.20%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 04-24
4月24日赛伦生物跌9.20%，中信保诚多策略混合(LOF)A基金重仓该股
4月22日赛伦生物涨5.03%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 04-22
4月22日赛伦生物涨5.03%，中信保诚多策略混合(LOF)A基金重仓该股
4月20日赛伦生物涨8.36%，易方达丰惠混合基金重仓该股
证券之星 · 04-20
4月20日赛伦生物涨8.36%，易方达丰惠混合基金重仓该股
3月30日赛伦生物涨6.06%，易方达丰惠混合基金重仓该股
证券之星 · 03-30
3月30日赛伦生物涨6.06%，易方达丰惠混合基金重仓该股
赛伦生物（688163）披露关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告，3月23日股价下跌2.99%
证券之星 · 03-23
赛伦生物（688163）披露关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告，3月23日股价下跌2.99%
每周股票复盘：赛伦生物（688163）拟用5亿闲置募资做现金管理
证券之星 · 03-22
每周股票复盘：赛伦生物（688163）拟用5亿闲置募资做现金管理
每周股票复盘：赛伦生物（688163）2025年净利增16.76%
证券之星 · 03-01
每周股票复盘：赛伦生物（688163）2025年净利增16.76%
加载更多
公司概况
公司名称：
上海赛伦生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-11
主营业务：
上海赛伦生物技术股份有限公司的主营业务是抗血清抗毒素等的生产、研发和销售。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清，马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。
发行价格：
33.03
{"stockData":{"symbol":"688163","market":"SH","secType":"STK","nameCN":"赛伦生物","latestPrice":39.58,"timestamp":1779433201000,"preClose":39.9,"halted":0,"volume":1727185,"delay":0,"changeRate":-0.008,"floatShares":108000000,"shares":108000000,"eps":0.4491,"marketStatus":"已收盘","change":-0.32,"latestTime":"05-22 15:00:01","open":40.01,"high":41.75,"low":38.01,"amount":68415300,"amplitude":0.0937,"askPrice":39.58,"askSize":8,"bidPrice":39.56,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.4491,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":39.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":43.89,"lowLimit":35.91,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108220000,"isCdr":false,"pbRate":3.85,"roa":"--","peRate":88.131819,"roe":"0.05%","epsLYR":0.48,"committee":0.212121,"marketValue":4283000000,"turnoverRate":0.016,"status":1,"afterMarket":{"amount":0,"volume":0,"close":39.58,"buyVolume":0,"sellVolume":0,"time":1779435237558,"indexStatus":"已收盘 05-22 15:30:00","preClose":39.9},"floatMarketCap":4283000000},"requestUrl":"/m/hq/s/688163","defaultTab":"news","newsList":[{"id":"2637754063","title":"每周股票复盘：赛伦生物（688163）2025年扣非净利增50.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637754063","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637754063?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:08","pubTimestamp":1779566893,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，赛伦生物报收于39.58元，较上周的39.0元上涨1.49%。本周关注点来自业绩披露要点：2025年扣非后净利润同比增长50.91%。公司公告汇总方正证券承销保荐有限责任公司发布了关于上海赛伦生物技术股份有限公司2025年度持续督导跟踪报告。2025年度，公司营业收入1.96亿元，净利润5178.74万元，扣非后净利润同比增长50.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636783772","title":"赛伦生物（688163）披露2025年度持续督导跟踪报告，5月19日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636783772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636783772?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:19","pubTimestamp":1779185956,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，赛伦生物报收于39.8元，较前一交易日下跌0.82%，最新总市值为43.07亿元。近日，方正证券承销保荐有限责任公司发布了关于上海赛伦生物技术股份有限公司2025年度持续督导跟踪报告。报告指出，赛伦生物在持续督导期间依法合规运作，未发生需保荐机构公开发表声明的违法违规事项，亦无重大违规行为。2025年度，公司营业收入1.96亿元，净利润5178.74万元，扣非后净利润同比增长50.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900035294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636621810","title":"每周股票复盘：赛伦生物（688163）2025年年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2636621810","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636621810?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:37","pubTimestamp":1778963828,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，赛伦生物报收于39.0元，较上周的36.94元上涨5.58%。本周关注点来自公司公告汇总：赛伦生物2025年年度股东会审议通过利润分配方案、续聘审计机构等多项议案。来自公司公告汇总：上海市锦天城律师事务所确认赛伦生物2025年年度股东会召集、表决程序合法有效。上海市锦天城律师事务所就上海赛伦生物技术股份有限公司2025年年度股东会的召集和召开程序、出席会议人员资格、召集人资格、表决程序及表决结果出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035515","title":"赛伦生物（688163）披露2025年年度股东会决议公告，5月15日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035515","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635035515?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:54","pubTimestamp":1778856856,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，赛伦生物报收于39.0元，较前一交易日下跌0.94%，最新总市值为42.21亿元。该股当日开盘40.16元，最高40.61元，最低38.35元，成交额达9338.85万元，换手率为2.21%。近日，赛伦生物发布《2025年年度股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635001182","title":"赛伦生物（688163）披露首次公开发行持续督导保荐总结报告书，5月13日股价下跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635001182","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635001182?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:56","pubTimestamp":1778666201,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，赛伦生物报收于37.81元，较前一交易日下跌5.43%，最新总市值为40.92亿元。该股当日开盘39.81元，最高39.81元，最低36.9元，成交额达1.52亿元，换手率为3.72%。公告显示，作为赛伦生物首次公开发行股票并在科创板上市的保荐机构，方正证券的持续督导期自2022年3月11日至2025年12月31日届满。实际控制人范志和曾被留置并立案调查，后已于2023年10月29日解除留置。截至2025年12月31日，持续督导期限已满，保荐机构完成保荐总结工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635201756","title":"5月13日赛伦生物跌5.43%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635201756","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635201756?lang=zh_cn&edition=full","pubTime":"2026-05-13 16:31","pubTimestamp":1778661073,"startTime":"0","endTime":"0","summary":"证券之星消息，5月13日赛伦生物跌5.43%，收盘报37.81元，换手率3.72%，成交量4.03万手，成交额1.52亿元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.5523，较上一交易日下跌1.39%，近一年上涨36.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300029492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0048597586.USD","BK1184","LU0575583348.USD","160921","02378","LU1015430645.USD","BK0239","LU0211331839.USD","LU0251144936.SGD","688163","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633392814","title":"赛伦生物（688163）披露抗蜂毒血清获临床试验批准通知书，5月8日股价上涨2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633392814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633392814?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:27","pubTimestamp":1778232463,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，赛伦生物报收于36.94元，较前一交易日上涨2.61%，最新总市值为39.98亿元。赛伦生物于近日披露《自愿披露关于抗蜂毒血清获得药物临床试验批准通知书的公告》。公告显示，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意其自主研发的抗蜂毒血清开展临床试验。截至目前，国内外尚无同类抗蜂毒血清产品获批上市。该产品需完成后续临床试验并经审批后方可生产上市，短期内对公司业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633198191","title":"赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633198191","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633198191?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:46","pubTimestamp":1778143577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物(688163.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意公司申报的抗蜂毒血清开展临床试验。抗蜂毒血清是公司自主研发、拥有独立知识产权的治疗用生物制品1类创新药，含有特异性抗体，具有中和蜂毒的作用。公司自主研发的抗蜂毒血清作为一种含有多克隆抗体的血清，作用机制明确，能够特异性中和蜂毒，从而减轻或消除其对人体造成的损害。与现有的急救措施和对症治疗手段相比，抗蜂毒血清能够从源头上中和蜂毒抗原，阻止毒素与靶细胞结合，从治疗机理上具有显著的治疗优势，有望为蜂蜇伤患者提供更加有效的治疗手段、填补对抗蜂毒毒素药物的空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633113425","title":"赛伦生物（688163）披露2025年年度股东会会议资料，5月6日股价上涨0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633113425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633113425?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:46","pubTimestamp":1778078777,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，赛伦生物报收于35.35元，较前一交易日上涨0.43%，最新总市值为38.26亿元。该股当日开盘35.9元，最高36.56元，最低34.81元，成交额达7862.3万元，换手率为2.03%。近日，赛伦生物发布《2025年年度股东会会议资料》。公告显示，2025年公司实现营业收入19,620.59万元，同比增长0.66%；归属于上市公司股东的净利润5,178.74万元，同比增长16.93%。同时提请授权董事会进行2026年中期分红，并拟使用部分超募资金增加募投项目投资及补充流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600040132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632625403","title":"每周股票复盘：赛伦生物（688163）将参加2026年5月13日业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625403","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632625403?lang=zh_cn&edition=full","pubTime":"2026-05-02 07:18","pubTimestamp":1777677493,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，赛伦生物报收于35.2元，较上周的37.0元下跌4.86%。本周，赛伦生物4月30日盘中最高价报36.78元。本周关注点公司公告汇总：赛伦生物将参加2026年5月13日举行的生物制品行业集体业绩说明会。投资者可于2026年5月6日至5月12日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630365775","title":"4月27日赛伦生物跌5.22%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630365775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630365775?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:28","pubTimestamp":1777278528,"startTime":"0","endTime":"0","summary":"证券之星消息，4月27日赛伦生物跌5.22%，收盘报35.07元，换手率5.09%，成交量5.51万手，成交额1.9亿元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.443，较上一交易日上涨0.94%，近一年上涨36.73%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700029235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1880383366.USD","LU0575583348.USD","160921","LU0211331839.USD","688163","02378","LU1015430645.USD","BK1184","BK0239","LU0251144936.SGD","LU0048597586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870550","title":"赛伦生物(688163)3月31日股东户数0.73万户，较上期增加8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870550","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870550?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:06","pubTimestamp":1777107998,"startTime":"0","endTime":"0","summary":"证券之星消息，近日赛伦生物披露，截至2026年3月31日公司股东户数为7269.0户，较12月31日增加595.0户，增幅为8.92%。在生物制品行业个股中，赛伦生物股东户数低于行业平均水平，截至3月31日，生物制品行业平均股东户数为3.6万户。从股价来看，2025年12月31日至2026年3月31日，赛伦生物区间涨幅为27.1%，在此期间股东户数增加595.0户，增幅为8.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630821835","title":"图解赛伦生物年报：第四季度单季净利润同比增长33.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630821835","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630821835?lang=zh_cn&edition=full","pubTime":"2026-04-25 01:36","pubTimestamp":1777052208,"startTime":"0","endTime":"0","summary":"证券之星消息，赛伦生物2025年年报显示，当年度公司主营收入1.96亿元，同比上升0.66%；归母净利润5178.74万元，同比上升16.93%；扣非净利润4263.28万元，同比上升50.91%；其中2025年第四季度，公司单季度主营收入2106.73万元，同比下降2.58%；单季度归母净利润-1242.33万元，同比上升33.41%；单季度扣非净利润-1380.28万元，同比上升37.46%；负债率3.85%，投资收益917.59万元，财务费用-134.05万元，毛利率78.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500004525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629816919","title":"4月24日赛伦生物跌9.20%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629816919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629816919?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:28","pubTimestamp":1777019280,"startTime":"0","endTime":"0","summary":"证券之星消息，4月24日赛伦生物跌9.20%，收盘报37.0元，换手率4.94%，成交量5.35万手，成交额2.02亿元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.4202，较上一交易日下跌0.84%，近一年上涨36.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400049911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160921","LU0211331839.USD","LU0575583348.USD","LU1015430645.USD","688163","LU0251144936.SGD","LU0048597586.USD","LU1880383366.USD","02378","BK0239","BK1184"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629156200","title":"4月22日赛伦生物涨5.03%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629156200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629156200?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:28","pubTimestamp":1776846494,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日赛伦生物涨5.03%创60日新高，收盘报41.79元，换手率3.64%，成交量3.94万手，成交额1.61亿元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.4413，较上一交易日下跌0.04%，近一年上涨37.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200037696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239","LU1015430645.USD","LU0211331839.USD","LU0251144936.SGD","BK1184","LU0575583348.USD","160921","LU1880383366.USD","02378","LU0048597586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628748268","title":"4月20日赛伦生物涨8.36%，易方达丰惠混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628748268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628748268?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:17","pubTimestamp":1776673058,"startTime":"0","endTime":"0","summary":"证券之星消息，4月20日赛伦生物涨8.36%创60日新高，收盘报38.25元，换手率3.85%，成交量4.17万手，成交额1.52亿元。重仓赛伦生物的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为易方达基金的易方达丰惠混合。易方达丰惠混合目前规模为0.98亿元，最新净值1.445，较上一交易日上涨0.07%，近一年上涨2.89%。该公募基金现任基金经理为罗川。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000021308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397234","title":"3月30日赛伦生物涨6.06%，易方达丰惠混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623397234?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:25","pubTimestamp":1774859115,"startTime":"0","endTime":"0","summary":"证券之星消息，3月30日赛伦生物涨6.06%，收盘报26.95元，换手率3.58%，成交量3.87万手，成交额1.02亿元。重仓赛伦生物的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为易方达基金的易方达丰惠混合。易方达丰惠混合目前规模为0.98亿元，最新净值1.419，较上一交易日上涨0.5%，近一年上涨2.89%。该公募基金现任基金经理为罗川。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621774983","title":"赛伦生物（688163）披露关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告，3月23日股价下跌2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621774983","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621774983?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:56","pubTimestamp":1774259769,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，赛伦生物报收于22.03元，较前一交易日下跌2.99%，最新总市值为23.84亿元。该股当日开盘22.41元，最高22.73元，最低21.88元，成交额达4721.44万元，换手率为1.96%。公司于近日披露《关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告》。同意公司在募投项目实施期间，先行使用自有资金支付项目人员薪酬等费用，后续定期从募集资金专户划转等额资金至公司自有账户进行置换。上述事项无需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300028306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621468799","title":"每周股票复盘：赛伦生物（688163）拟用5亿闲置募资做现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621468799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621468799?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:06","pubTimestamp":1774119973,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，赛伦生物报收于22.71元，较上周的24.03元下跌5.49%。本周关注点公司公告汇总：赛伦生物拟使用最高不超过5亿元的暂时闲置募集资金进行现金管理。方正证券承销保荐有限责任公司关于上海赛伦生物技术股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见上海赛伦生物技术股份有限公司拟使用不超过5亿元的暂时闲置募集资金进行现金管理，期限自董事会审议通过之日起不超过12个月，资金可循环滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616437458","title":"每周股票复盘：赛伦生物（688163）2025年净利增16.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616437458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616437458?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:20","pubTimestamp":1772302824,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，赛伦生物报收于25.5元，较上周的26.03元下跌2.04%。本周，赛伦生物2月25日盘中最高价报26.47元。本周关注点来自业绩披露要点：赛伦生物2025年归属净利润同比增长16.76%。业绩披露要点赛伦生物近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利0.517亿元，同比增长16.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779649623953,"stockEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.5206},{"period":"6month","weight":0.7701},{"period":"1year","weight":1.2484},{"period":"ytd","weight":0.8181}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.0725},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海赛伦生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7269人(较上一季度增加8.92%)","perCapita":"14887股","listingDate":"2022-03-11","address":"上海市青浦区华青路1288号","registeredCapital":"10822万元","survey":" 上海赛伦生物技术股份有限公司的主营业务是抗血清抗毒素等的生产、研发和销售。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清，马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。","listedPrice":33.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛伦生物,688163,赛伦生物股票,赛伦生物股票老虎,赛伦生物股票老虎国际,赛伦生物行情,赛伦生物股票行情,赛伦生物股价,赛伦生物股市,赛伦生物股票价格,赛伦生物股票交易,赛伦生物股票购买,赛伦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}